🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Depression, Bipolar

A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults NCT06508450NA1 site📍 The Bronx New York University · Tests: Just Do You, Component A, Component B, Component C Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients NCT06372964Phase 368 sites📍 Dothan📍 Little Rock📍 Anaheim Intra-Cellular Therapies, Inc. · Tests: Lumateperone, Placebo Taking Action for College Students NCT06700902NA1 site📍 Philadelphia Temple University · Tests: Taking Action The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects NCT05786066Phase 21 site📍 West Haven Yale University · Tests: Perampanel 6 MG, Ketamine, Placebo Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects NCT06507787NA7 sites📍 Erstein📍 Issy-les-Moulineaux📍 La Roche-sur-Foron Alcediag · Tests: EDIT-B test, EDIT-B test (without giving result) Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy NCT07619092NA1 site📍 Frederiksberg Anders Jørgensen · Tests: Flumazenil, Electroconvulsive therapy (ECT) Chinese Longitudinal and Systematic Study of Bioplar Disorder NCT05480150NA1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Escitalopram Oxalate Tablets, Quetiapine Fumarate Tablets, Lurasidone BioClock: Bright Light Therapy for Depressive Disorders NCT05958940NA2 sites📍 Eindhoven📍 Leiden Universiteit Leiden · Tests: Bright Light Therapy, Blue Light Blocking Glasses The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry NCT02443636n/a1 site📍 Halifax Nova Scotia Health Authority Longitudinal Study on the Sustainability of Transcranial Magnetic Stimulation Protocols - Biomarkers NCT07684911n/a1 site📍 Rennes Hospital Center Guillaume Régnier · Tests: Repetitive transcranial magnetic stimulation HD-tDCS for Adolescent Bipolar Depression Targeting S1 NCT07246044NA1 site📍 Nanjing Jiangsu Province Nanjing Brain Hospital · Tests: Active HD-tDCS, Antipsychotics, mood stabilizers, etc., Sham HD-tDCS The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression NCT07699445Phase 41 site📍 Boston Massachusetts General Hospital · Tests: Lumateperone 42 mg A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder NCT07031661n/a1 site📍 Shanghai Shanghai Mental Health Center · Tests: This was an observational study with no intervention. Suicidal Behavior in Patients Diagnosed With Bipolar Disorder NCT02604277NA1 site📍 Atlanta Emory University · Tests: Interpersonal and Social Rhythm Therapy (ISRT), Bipolar-Specific Cognitive Behavioral Therapy (CBT), Mindfulness-Based … COMpassion for Psychiatric Disorders And Self-Stigma NCT05698589NA7 sites📍 Bordeaux📍 Bron📍 Clermont-Ferrand University Hospital, Strasbourg, France · Tests: Compassion Focused Therapy, Ending Self Stigma NMDA Receptor Modulation for the Treatment of Bipolar I Disorder NCT05977023Phase 21 site📍 Taichung China Medical University Hospital · Tests: NMDAE, Placebo Cap ALTO-100 in Bipolar Disorder With Depression (BD-D) NCT06656416Phase 268 sites📍 Birmingham📍 Chandler📍 Phoenix Alto Neuroscience · Tests: ALTO-100, Placebo Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder NCT05457465Phase 21 site📍 Belmont Mclean Hospital · Tests: Cannabidiol Prediction on the Recurrence of Manic and Depressive Episodes in Bipolar Disorder NCT05828056n/a1 site📍 Taipei National Taiwan University Hospital · Tests: Wearable activity tracker Safety and Feasibility of DBS for Bipolar Depression NCT07745374NA1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Medtronic Percept PC DBS system Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder NCT07031817NA1 site📍 Montpellier University Hospital, Montpellier · Tests: Venous blood sample for measuring blood biomarkers related to bipolar disorder, Standardized psychiatric assessment too… Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression NCT05480826NA1 site📍 Créteil Fondation FondaMental · Tests: study of the transmission of genetic variants A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder NCT06696755Phase 233 sites📍 Huntsville📍 Chandler📍 Tucson AbbVie · Tests: Icalcaprant, Placebo for Icalcaprant Immune Mechanisms of Antipsychotic Treatment Response NCT06687694n/a1 site📍 London King's College London Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital NCT07359157NA1 site📍 Worcester Massachusetts General Hospital · Tests: Changing Lives and Changing Outcomes-9 Non-invasive BCI and Application Verification for Depressed People NCT06417437Phase 41 site📍 Shanghai Shanghai Mental Health Center · Tests: SSRI, rTMS, Neuro-Feedback, Game Regulation Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. NCT07494305Phase 226 sites📍 Bentonville📍 Little Rock📍 Bellflower LB Pharmaceuticals Inc. · Tests: LB-102, Placebo Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers NCT00024635n/a1 site📍 Bethesda National Institute of Mental Health (NIMH) Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study NCT06831435NA1 site📍 Beijing Peking University · Tests: a digital product based on CBT Pharmacogenomics-Supported Psychotropic Prescribing Trial NCT06929533NA2 sites📍 Winnipeg📍 Winnipeg University of Manitoba · Tests: Pharmacogenetic Testing
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy